Artiva Biotherapeutics, Inc. Current Assets
Artiva Biotherapeutics, Inc. (ARTV) had Current Assets of $352.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $352.28M.
- 2026-03-31: Assets, Current $88.74M.
- 2025-12-31: Assets, Current $112.67M.
- 2025-09-30: Assets, Current $129.52M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $352.28M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $88.74M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $112.67M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $129.52M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $149.07M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $170.00M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $188.63M 10-K · filed 2026-03-10 |
| 2024-09-30 | $150.56M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $49.75M 10-Q · filed 2024-08-29 |
| 2023-12-31 | $79.82M 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |